awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42361869-03256C35-8F16-41FD-9B69-2C4509DD2E12
Q42361869-03256C35-8F16-41FD-9B69-2C4509DD2E12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42361869-03256C35-8F16-41FD-9B69-2C4509DD2E12
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields).
P2860
Q42361869-03256C35-8F16-41FD-9B69-2C4509DD2E12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42361869-03256C35-8F16-41FD-9B69-2C4509DD2E12
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f38167429f154f063717f82eca376feff3e8fd4a
P2860
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.